prix galien russia 2013 awards ceremony draft program...

Sponsored by:

Prix Galien Russia 2013 AWARDS CEREMONY

DRAFT PROGRAM

19h-20h00 WELCOME COCKTAIL

20h00 DINNER AND AWARDS CEREMONY

Video presentation of Prix Galien Russia and Thank you to sponsors, partners, supporters

20h25: WELCOME REMARKS: French Ambassador

Opening Speech: Prix Galien Russia General Secretary

Words from the President of the Jury

20h35: Prix Galien Pro Bono Humanum Awards

Medal presented by President of the Jury + VIP

Acceptance speech by Prof. Alexander Rumantsyev

20h40: AWARDS CEREMONY

Keynote Address: H.E. Veronika Skvortsova, Minister of Health of RF

Best Research in Russia Presentation of Candidates

Medal presented by H.E. Minister of Health of Russia + VP of the Jury

Short Speech by jury member

Acceptance words by laureate

Best Biopharmaceutical Product Presentation of Candidates

Medal presented by member of the Jury + VIP

Short speech by jury member


Best Pharmaceutical Agent Presentation of Candidates

Medal Presented by member of jury + VIP

Short Speech by jury about the laureate


21h00: CLOSING REMARKS:

Florence Mehl General Secretary of Prix Galien International

Final Words: Alexey Komissarov - Moscow Government Minister and Head of the

Department of Science, Industrial Policy and Entrepreneurship

21h10: DESSERT PARTY and MUSICAL BREAK

Sponsored by:

THE PRIX GALIEN RUSSIA AWARDS For the first time, the Prix Galien Russia Awards will be bestowed in a gala award ceremony on October 24th 2013 in Moscow. Winners will be selected by a distinguished body of scientists. One winner will be announced in each of the following categories:

Best Therapeutic Research in Russia

Best Pharmaceutical Agent

Best Biotechnology Product

Selection Committee: Prof. Sergey Bachurin: Director of the Institute of Phisiologically Active Compounds of the Russian Academy of Science Prof. Alexander Chuchalin (President) – Director of Pulmonology Research Institute, Head of the Department of Hospital Therapy, Pediatric Faculty, Russian Medical State University Prof. Vladimir Ivashkin – President of Russian Gastroenterological Association Prof. Eugeny Nasonov – Director of Research Institute of Rheumatology of RAMS Prof. Rem Petrov – Academician Prof. Dmitry Pushkar – Chief Urologist Ministry of Health and Social development of the Russian Federation Prof. Gennady Sukhikh – Director FSI Obstetrics, Gynecology and Neonatology Research Institute Prof. Evgeny Sverdlov – Head of the Genetics and Postgenomic Technologies Dpt of the Shemyakin-Ovchinnikov Institute of Bioorganic Prof. Michael Ugrumov (vice-president) – Head of the Laboratory of Hormonal Regulations of the Institute of Developmental Biology of the RAS, Advisor to the President of RAS

Sponsored by:

The Prix Galien Award The Prix Galien was created in France in 1970 by a pharmacist named Roland Mehl. Its aim was to promote significant advances in pharmaceutical research. Until the creation of the Prix Galien, this field of research had remained largely unrecognized. A prominent jury was brought together, including clinicians, toxicologists, pharmacologists and pharmacists. Each year, the award has been an opportunity to give credit to the most important drugs introduced into the public market as well as to the achievements of the best research team in the pharmaceutical field. Since its creation, the Galien award has grown into a major event. It is seen as an influential event by all those interested in pharmaceutical research, including public authorities, scientists, pharmaceutical companies and medical press groups. For this reason, it is also considered as the industry’s equivalent of the Nobel Prize and the highest accolade for pharmaceutical research and development. Prix Galien Around the World The importance of the Prix Galien in France has led to similar initiatives in several other countries. The first countries other than France to create their own Galien award were Belgium and Luxemburg in 1982, followed in 1984 by Germany, and in 1985 by the Netherlands. In 1988 the United Kingdom created a Galien award, followed in 1989 by Italy, in 1990 by Spain, in 1992 by Portugal, in 1993 by Canada, in 2001 by Switzerland and in 2007 by the United States, in 2012, Poland, Israël, Greece and Singapore. In addition, a European Galien award was created in 1990 in Paris to reward one of the winners of the national Galien awards of the two previous years. This prize was also awarded in Brussels in 1992 and in Berlin in 1994. After Canada introduced its own prize, the European Galien award was turned into an International Galien award in 1996, in London. The 30th ceremony of the French prix Galien and the 5th ceremony of the International Galien award took place at Unesco on 10 February 1999. On this occasion, a prominent honorary committee was invited, including four Nobel laureates. Montreal organised the International Galien award in 2000, Madrid did so in 2002 and Lisbon in 2004, in Zurich in 2006. The 10th anniversary of the international prix Galien was awarded in Berlin in October 2008, in New York in 2010 and in Lyon in 2012. Israel will welcome the International Prix Galien in 2014.

Sponsored by:

Prix Galien Russia News

Minister of Health, Veronika Skvortsova to be Keynote Speaker at first

Prix Galien Russia Ceremony

October 09, 2013

The Prix Galien Russia Committee received confirmation that Veronika Skvortsova, Minister

of Health of the Russian Federation will be the keynote speaker at the Prix Galien Russia

2013 ceremony.

“It is an immense pleasure to receive such support from Prof. Skvortsova. Her presence at the

ceremony not only enhances the visibility of this important event, but it is also highly

symbolic for all candidates as Prof. Skvotsova is herself a scientist and a doctor who

understands well the value of therapeutic research.” Said Frédéric Boucheseiche, General

Secretary of Prix Galien Russia.

The Prix Galien Russia awards will honor companies and researchers who have made

innovative contributions to biopharmaceutical and medical technology research and

development. Prix Galien Russia 2013 will be held at the SwissÔtel Krasnye Holmy

Conference Center in Moscow on the 24th of October, 2013.

About Prix Galien Russia:

A Jury of eminent specialists involved in the sphere of Russian and international

pharmaceutical research will announce the laureates in three categories: Best Research in

Russia, Best Pharmaceutical Agent, Best Biopharmaceutical Product.

Around the world, the Prix Galien awards outstanding achievements in improving the global

human condition through the development of innovative therapies.

To attend or support the Prix Galien 2013 awards ceremony contact: Crystelle Coury

[email protected]

mailto:[email protected]

Sponsored by:

Dina Korzun, Chulpan Xhamatova and Alexander Rumyantsev selected as

2013 Pro Bono Humanum honorees by Prix Galien Russia

October 09, 2013

The Prix Galien Russia Committee, responsible for awarding the most prestigious prize in

biopharmaceutical research and development, announced today that Dina Korzun, Chulpan

Xhamatova and Alexander Rumyantsev of the “Gift of Life Charity Foundation” (Podari

Zhizn) will be awarded the 2013 Pro Bono Humanum Award during the 1st Annual Prix

Galien Russia Award Ceremony.

The Prix Galien Russia Committee selected this year’s laureate for their commendable actions

to offer hope and practical care to children and young adults whose families cannot afford

treatment for cancer, hematologic and other life-threatening illnesses. Their work has saved

the lives of dozens of children through the provision of vital medicine.

The Pro Bono Humanum Award is presented by the Prix Galien Russia Committee to

exemplary individuals, companies, academic institutions or non-governmental organizations

that have made innovative efforts to improve access to biopharmaceutical treatment for

underserved populations, and as such, improving the human condition.

This special award will be presented to Professor Alexander Rumantsyev, director of the

Federal Dmitry Rogachev Research Clinical Center of Children’s Hematology, chief

hematologist of the Russian Federation and Head of the Department of Pediatrics of the

Russian State Medical University, in the presence of the Prix Galien Russia selection

committee; H.E. Veronika Skortsova, Minister of Health of Russia and H.E. Jean de

Gliniasty, Ambassador of France to the Russian Federation.

The annual presentation of the Pro Bono Humanum Award accompanies a series of other

awards honoring companies and researchers who have made innovative contributions to

biopharmaceutical and medical technology research and development. Prix Galien Russia

2013 will be held at the SwissÔtel Krasnye Holmy Conference Center in Moscow on the 24th

of October, 2013.


The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A

jury of eminent specialists involved in the sphere of Russian and international pharmaceutical

research will announce the laureates in three categories: Best Therapeutic Research in Russia,

Best Pharmaceutical Agent and Best Biopharmaceutical Product.

Around the world, the Prix Galien awards outstanding achievements to improve the human

condition worldwide through the development of innovative medical therapies.

Sponsored by:

To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please

contact Crystelle Coury : [email protected]

Prof. Leonid Roshal, Dr. Yuri Kalinin and Prof. André Syrota are

designated honorary members of the Prix Galien Russia Committee

October 09, 2013

Frédéric Boucheseiche, General Secretary of Prix Galien Russia, announced today that

Professor Leonid Roshal, President of the National Medical Chamber of Russia, Doctor Yuri

Kalinin, President of “Rosmedprom” and Professor André Syrota, President of Inserm,

France’s most important public scientific and technological institute, have agreed to join the

Prix Galien Russia Committee as honorary members.

The General Secretary declared: “It is incredible to count with the support of such

personalities for the first edition of Prix Galien Russia. It shows that our initiative is not only

receiving great interest in Russia, but also abroad. Although their role is purely honorary, I am

sure that there presence on our board will greatly contribute to the future impact and

importance of Prix Galien in Russia.”










Prix Galien Russia Ceremony to be broadcast live on Internist.ru

October 09, 2013

Oxana Drapkina, Vice President of the Russian Internet Society for Internists:

(Национальное Интернет Общество специалистов по внутренним болезням) and

Frédéric Boucheseiche, General Secretary of Prix Galien Russia, are pleased to announce that

the first edition of Prix Galien Russia will be broadcast live on www.internist.ru .



http://www.internist.ru/

Sponsored by:

“We are very happy to build a long term partnership with the Prix Galien Russia, as our

audience is very much interested in such important events. It is important that Russian doctors

and regional healthcare and medical scientific organizations, especially in the regions, are

fully aware about the Prix Galien Russia. We are already receiving many inquiries from the

regions and we expect an audience of around 8,000 doctors”, said Drapkina.

“The partnership with Internist.ru is very valuable, as it will allow doctors and scientists from

all over Russia and the CIS to be aware of Prix Galien while following the event live to

discover together with our audience the names of the laureates”, added Frédéric

Boucheseiche.

Already more than 170 guests have confirmed their presence at the first Prix Galien Russia

awards ceremony. The black-tie cocktail and gala dinner will take place at Moscow’s

SwissÔtel Krasnye Holmy Conference Center on the 24th of October 2013.

Other media and information partners of Prix Galien Russia are Cegedim,

PharmaBoardroom.com, Pharmaceutical Executive (USA), Ria Ami and Vademecum.

About Russian Internet Society for Internists:

The Russian Internet Society for Internists supports international education programs for

physicians around Eastern Europe, Russia and CIS. The Society is the educational TV

broadcast partner of the Russian Gastroenterology Association, the Russian Cardiology

Society and the Therapeutic Council of Russian Academy of Medical Sciences. It records and

broadcasts live selected sessions and symposiums of annual events of those bodies on the

website Internist.ru.









contact Crystelle Coury: [email protected]


Sponsored by:

Prix Galien Russia 2013 receives broad industry support

October 04, 2013

Sponsors of the first edition of the Prix Galien Russia award ceremony include Aston

Consulting, E&Y, IMS, PharmaBoardroom.com, Santens Service and Technopolis Moscow.

Already more than 170 guests have confirmed their presence at the first Prix Galien Russia

awards ceremony. The black-tie cocktail and gala dinner will take place at Moscow’s

SwissÔtel Krasnye Holmy conference center on the 24th

of October 2013.

Laureates of three categories will be announced in the presence of the selection committee

and influential industry guests. Amongst the prominent figures attending the ceremony are

H.E. Veronika Skvortsova, Minister of Health of Russia and H.E. Jean de Gliniasty,

Ambassador of France to the Russian Federation. Representatives of the following companies

will also be present at the event: Abbott Diagnostics, Abbvie, Amgen, Arval (BNP Paribas

Group), Aston Consulting, Astra Zeneca, Baxter, Besins Healthcare, Bristol-Myers Squibb,

Boehringer Ingelheim , Cegedim, Chiesi, Deloitte, Ernst & Young, Ferring, F.Hoffmann-La

Roche Ltd., Generium, GFK, IMS, Janssen, Kuehne + Nagel, Lilly, Les Laboratoires Servier,

Mayoly Spindler, Merck Serono, Merz, Metamax, Mitotech, MSD Pharmaceuticals, Nova

Medica, Novartis, Novo Nordisk, Oncomax, Pfizer, Pharma Bio, Pharm-Syntez, PwC,

Quantum Pharma, R-Pharm, Santens Service, SAP, Skolkovo Foundation, Takeda,

Technopark Mosgormash, Technopolis Moscow, UCB…











Sponsored by:

Prix Galien Russia 2013 Nominees for “Best Research in Russia,” “Best

Pharmaceutical Agent” and “Best Biotechnology Product” announced.

Winners to be Recognized by Research and Academic Leaders at October

24th Award Ceremony in Moscow

August 01, 2013

Focus Reports, organizer of the Prix Galien Russia, today announced the 2013 nominees for

the first annual Prix Galien Russia Awards. The Prix Galien Award is considered the

biomedical industry’s highest accolade and recognizes the technical, scientific and clinical

research skills necessary to develop innovative medicines.

Nominees include research programs lead in Russia by companies and academic institutes and

biomedical products that advance the human condition and which were approved by the

Russian Ministry of Health during the past five years.

Nominees for the Prix Galien Russia 2013 Awards are:

Best Research in Russia (Nominees)

DIASKINTEST® CSJC “GENERIUM”

MM-D37K® Metamax Ltd

SkQ – mitochondrially targeted antioxidant (Visomitin ®) Mitotech LLC

OM-RCA-01® Oncomax Ltd

C12-OB® Pharma Bio LLC

Timodepressin® Pharma Bio LLC

Inhibitor of the HIV virus matrixprotein p17/MA® Quantum Pharmaceuticals LLC

Modular nanotransporters®

Russian Academy of Sciences

Professor Alexander S. Sobolev,

Head, Laboratory of Molecular

Genetics of Intracellular Transport

Institute of Gene Biology

Best Pharmaceutical Agent (Nominees)

TICAGRELOR (BRILINTA®) AstraZeneca

Sponsored by:

Sorafenib (Nexavar ®) Bayer HealthCare

Iloprost (Ventavis ®) Bayer HealthCare

Rivaroxaban (Xarelto ®) Bayer HealthCare

Ethinylestradiol + Drospirenone + Levomefolate

Calcium (Yaz Plus ®)

Bayer HealthCare

Estradiol Valerate (Qlaira ®) Bayer HealthCare

Dienogest (Visanne ®) Bayer HealthCare

Dabigatran etexilat (Pradaxa®) Boehringer Ingelheim

Telaprevir (INCIVO ®) JANSSEN

Abiraterone (ZYTIGA ®) JANSSEN

Pemetrexed (Alimta®) Eli Lilly

Sitagliptin+metformin (Janumet ®) MSD Pharmaceuticals

Raltegravir (Isentress ®) MSD Pharmaceuticals

Everolimus (Afinitor ®) Novartis Pharma

Vildagliptin (Galvus ®) Novartis Pharma

Fingolimod (Gilenya ®) Novartis Pharma

Nilotinib (Tasigna ®) Novartis Pharma

Agomelatine (Valdoxan ®) Les Laboratoires Servier

IVABRADINE (Coraxan ®) Les Laboratoires Servier

Roflumilast (Daxas ®) Takeda

Best Biotechnology Product (Nominees)

Adalimumab (Humira®) AbbVie

Denosumab (Xgeva®) Amgen

Sponsored by:

Abatacept (ORENCIA®) Bristol-Myers Squibb

Teriparatide (Forsteo®) Eli Lilly

Cetuximab (Erbitux®) Merck Serono, division of Merck

Epoetin alfa (Binocrit®) Sandoz

Canakinumab (Ilaris®) Novartis Pharma

ranibizumab (Lucentis®) Novartis Pharma

Tocilizumab (ACTEMRA®) F.Hoffmann-La Roche Ltd.

The Prix Galien Russia Committee comprised of nine renowned leaders in biomedical

research is responsible for evaluating nominees. Winners will be honored at the Prix Galien

Russia Award Ceremony in the SwissÔtel convention center, on the 24th of October 2013.

“This first Edition of the Prix Galien Russia can already be considered a success, looking at

the number and variety of candidates and the quality of the Jury”, remarked Frédéric

Boucheseiche, General Secretary of the Prix Galien Russia. “We are proud to honor those that

drive progress in medical science and improve human condition through their innovations,

research efforts and dedication.”


The Prix Galien Russia will be inaugurated in Moscow, Russia in 2013 under the auspice of

an exceptional awards committee composed of eminent specialists involved in the sphere of

Russian and international pharmaceutical research.

Around the world, the Prix Galien awards outstanding achievements in improving the global

human condition through the development of innovative therapies.




Sponsored by:

Deadline for Prix Galien – Research in Russia extended

June 28, 2013

The Prix Galien Russia General Secretary announced today that the deadlines for participation

in the Prix Galien - Research in Russia Special Prize are extended to July 15th (to officially

confirm participation and return the booking form) and July 30th (to submit the application

files).

As a reminder, the Research in Russia Special Prize is open to academia, healthcare

institutions, research centers, and companies that have been involved in bio-pharmaceutical

research in Russia for at least three years. Applicants must demonstrate a substantial

contribution to the diagnosis, prevention, or treatment of disease.

The first Prix Galien Russia medals will be awarded in three categories during an exclusive

Gala Dinner ceremony on the 24th

of October 2013 at the SwissÔtel Moscow Convention

center.

To apply or recommend candidates for the Special Prize, attend the Gala dinner, become a

sponsor, or for further enquiries about Prix Galien Russia, please contact Crystelle Coury

at [email protected] or on this site.

First Prix Galien Russia generates great interest

June 14, 2013

AbbVie, Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Janssen, Lilly, Merck,

MSD, Novartis, Roche, Servier, and Takeda will all submit one or more products in the Best

Pharmaceutical Agent and/or Best Biotechnological Product categories of the competition.

Applications in those two categories are now closed.

With 14 multinational biopharmaceutical companies confirming their participation with a

total of 30 products, the first Prix Galien Russia can already be called a success. Frédéric

Boucheseiche, General Secretary of the Prix Galien Russia, said of the turnout, “this really

exceeds our expectations, and we would like to thank all the participants for their support. We

are more than happy about both the number and quality of the applications we are receiving,

and the enthusiasm shown by pharmaceutical companies for the first national committee of

the Prix Galien.”

The winners will be announced at the Gala dinner, to take place at the SwissÔtel convention

center in Moscow on the 24th

of October 2013.


Sponsored by:

For the special Prize for Research in Russia, Oncomax and Metamax—two companies backed

by Maxwell Biotech Group, an RVC investment fund—have already confirmed their

participation. So have Mitotech, a company backed by Rusnano and Generium.

Applications in this category will be accepted until the end of June. The Prize is open to

academia, health care institutions, research centers, and companies that have been involved in

biopharmaceutical research in Russia for at least three years. Applicants must demonstrate a

substantial contribution to the diagnosis, prevention, or treatment of disease.

To apply or recommend candidates for the Special Prize, attend the Gala dinner, become a

sponsor, or for further enquiries about Prix Galien Russia, please contact Crystelle Coury at

[email protected] or log on www.prixgalienrussia.com

Prix Galien Russia partners with Cegedim

June 05, 2013

Prix Galien Russia and Cegedim have agreed to cooperate in order to keep over 500.000

medical doctors in Russia informed on the prestigious award’s development and results.

Frédéric Boucheseiche general secretary of the Prix Galien Russia declared: “with its

unrivalled access to medical doctors, Cegedim was a natural choice for the Prix Galien

Russia. We are happy to have such a partner in order to keep a very large amount of medical

doctors in Russia informed about the results of the Prix Galien Russia different awards

category. We believe that no other company has such a privileged access to medical doctors

in Russia.”

Lucia Railean, Managing Director of Cegedim emphasized: “Prix Galien brings recognition to

the effort of pharmaceutical companies and researchers to improve the life of patients in

Russia and around the World. According to ROSSTAT data, between 2006-2011, only 4-7%

innovative drugs consumed in Russia were manufactured locally. The government targets to

bring this figure to 50% by 2020. This requires common efforts by all stakeholders to boost

R&D in Russia. In this regards, the Prix Galien comes at the right moment for Russia,

reminding us of the crucial role played by biopharmaceutical research to save lives. Cegedim

Russia is proud to be associated to this initiative.”

Organized for the first time in Moscow in 2013, the 9 eminent members of the independent

scientific selection committee of the Prix Galien Russia will nominate one winner in each of

the following categories: Best Pharmaceutical Agent, Best Biotechnology Product , Best

Research in Russia.

14 multinational biopharmaceutical companies have confirmed their participation. Abbvie,

Amgen, Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Janssen Pharmaceutica, Lilly,


http://www.prixgalienrussia.com/

Sponsored by:

Merck, MSD, Novartis, Roche, Servier and Takeda will all submit 30 products to the

following Jury:

Prof. Alexander Grigorievich Chuchalin (Chairman): Director FSI Pulmonogy Research

Institute. Academician of the RAMS

Prof. Sergey Olegovich Bachurin: Titular Member of the Division of “Chemistry and

Human Health” of the IUPAC and the Vice-Chairman of the Russian Society for Medicinal

Chemistry.

Prof. Vladimir Trofimovich Ivashkin: President of Russian Gastroenterological

Association. Academician of the RAMS

Prof. Eugeny Lvovich Nasonov: Director of Research Institute of Rheumatology

Prof. Rem Viktorovich Petrov: Vice President of the Russian Academy of Sciences

Prof. Dmitry Yurievich Pushkar: Chief Urologist Ministry of Health and Social

development of the RF

Prof. Gennady Tikhonovich Sukhikh: Director FSI Obstetrics, Gynecology and

Neonatology Institute

Prof. Evgeny Davidovich Sverdlov: Head of the Genetics and Postgenomic Technologies

Dpt of the Shemyakin-Ovchinnikov Institute of Bioorganic

Prof. Vsevolod Arsenievich Tkachuk: Dean of Faculty of Fundamental Medicine M.V.

Lomonosov State University

Prof. Michael Veniaminovich Ugrumov (Vice Chairman) – Head of the Laboratory of

Hormonal Regulations of the Institute of Developmental Biology of the RAS

The laureates will be receiving a medal during a gala dinner on the 24th

of October at

SwissÔtel Moscow Convention center.

Around the world the prix Galien is considered highest accolade for the biopharmaceutical

pharmaceutical industry and often compared to the Nobel prize for the industry.

For more information about the Prix Galien Russia log onto: www.prixgalienrussia.com or



Sponsored by:

Prix Galien Russia Officially Launched

February 22, 2013

A VIP cocktail reception announcing the first Prix Galien Russia was hosted by Monsieur

Jean de Gliniasty, Ambassador of France to the Russian Federation and Frédéric

Boucheseiche, General Secretary of the Prix Galien Russia. The reception was held on

February 7 at the Igumnov House – was built in 1883 – 1893 to the design by Nikolay

Pozdeyev , residence of the French Ambassadors to Russia since 1979.

This reception marked the official launch of the Prix Galien Russia, which is set to quickly

become the highlight of the year underscoring innovation in the pharmaceutical industry in

Russia.

Globally, the Galien Award is the most coveted award for the pharmaceutical industry and

often regarded as the Nobel Prize for innovation in life sciences and biopharmaceutical

research. Founded over 40 years ago in France, there are now 16 countries organizing a

national Galien Prize. Russia is the latest country to join the list of organizing nations. Every

two years, laureate recipients of national awards compete in a global competition, The Prix

Galien International.

The event was attended by over 60 VIP guests including academicians and eminent scientists,

decision makers of the pharmaceutical industry.

After an introductory speech by the Ambassador and the General Secretary, the selection

committee was unveiled:

Prof. Alexander Grigorievich Chuchalin (Chairman of the committee)

Prof. Sergey Olegovich Bachurin

Prof. Vladimir Trofimovich Ivashkin

Prof. Eugeny Lvovich Nasonov

Prof. Rem Viktorovich Petrov

Prof. Dmitry Yurievich Pushkar

Prof. GennadyTikhonovich Sukhikh

Prof. Evgeny Davidovich Sverdlov

Prof. Michael Veniaminovich Ugrumov (Vice Chairman of the committee)

http://en.wikipedia.org/w/index.php?title=Nikolay_Pozdeyev&action=edit&redlink=1

http://en.wikipedia.org/w/index.php?title=Nikolay_Pozdeyev&action=edit&redlink=1

Sponsored by:

The selection committee is completely independent in the judging process and its decisions

are final. The Jury will select finalists in the following categories: Best Pharmaceutical Agent

(i.e. small molecule), Best Biotechnology Product .

The prizes will be awarded principally based on two criteria:

- What was innovative in the course of this product’s scientific development, application

or clinical utility?

- What was learned for the future of biomedical science from this product’s introduction

to the clinic?

Criteria that will NOT be considered are the size of the market, the size of the company, the

cost of development or the contingencies of distribution.

In addition, a special Prize named the “Prix Galien Russia – Research” will be awarded to the

researcher or the research team judged by the Selection Committee to have made the most

significant contribution to bio-pharmaceutical research in Russia.

The winners of each category will receive the prestigious commemorative Prix Galien Medal

in a gala dinner and awards ceremony in Moscow on October 24th, 2013. Over 200 guests,

including many academic, industry and government luminaries are expected to attend.

Photos of the event are available here

Russian transcripts of the speeches are available here

Russian translation of the letter of support of the Galien International Committee is available

here

For more information about the Prix Galien Russia 2013 you can log on

www.prixgalienrussia.com or contact [email protected] .

Prix Galien Russia selection committee to be announced on February 7,

2013

January 29, 2013

For the past 40 years, the Prix Galien has rewarded excellence in life sciences research and

innovation. It is often considered the Nobel of the pharmaceutical industry. Present with

national awards committees in over 15 countries around the World, the Prix Galien is finally

coming to Russia.

http://prixgalienrussia.com/en/photogallery/

http://prixgalienrussia.com/en/speeches/

http://prixgalienrussia.com/en/support_letters/



Sponsored by:

For the first time, on October 24, 2013, the Prix Galien Russia awards will be organized in

Moscow and an independent selection committee composed of eminent scientists of the

Russian Federation will announce a winner in each of the following categories:

- Best pharmaceutical agent

- Best Biotechnological product

- Prix Galien – Best research in Russia

Jean de Gliniasty, French Ambassador to Russia, and Focus Reports will co-host an

inauguration cocktail to officially launch the Prix Galien Russia. This ceremony will take

place at the Residence of the Ambassador, in Moscow on the February 7, 2013. During this

cocktail the Secretary General will announce the Prix Galien Russia selection committee.

For more information about application or sponsorship opportunities click here

http://prixgalienrussia.com/en/contact/

prix galien russia 2013 awards ceremony draft program...

Documents